FGC
EW icon

Financial Gravity Companies’s Edwards Lifesciences EW Stock Holding History

Financial Gravity Companies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Buy
+12
New +$1K ﹤0.01% 808
2024
Q4 		$888 Buy
+12
New +$840 ﹤0.01% 821
2018
Q4 		$10K Buy
+180
New +$9.11K 0.01% 586
2018
Q1 		$12K Sell
264
-174
-40% -$7.56K 0.01% 562
2017
Q4 		$18K Buy
+438
New +$16.1K 0.02% 492

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Financial Gravity Companies's EW Position: Q2 2026 in Review

Financial Gravity Companies opened a new position in Edwards Lifesciences (EW) in Q2 2026: 12 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #808 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in EW as recently as Q4 2024.

Financial Gravity Companies first reported a position in EW in Q4 2017 and has held it in 5 quarters since. The position peaked at $18K in Q4 2017. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Financial Gravity Companies held 12 shares of Edwards Lifesciences worth $1.09K as of Q2 2026.
  • Edwards Lifesciences was a new Financial Gravity Companies position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2026, its #808 holding.
  • Financial Gravity Companies first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 5 quarters since.
  • Financial Gravity Companies's Edwards Lifesciences position peaked at $18K in Q4 2017.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.